Bond.az White LogoBond.az Black Logo

Anterix stock hits 52-week high at $59.44

Anterix stock hits 52-week high at $59.44. 1-year change +102%, 6-month surge +163%. FCC license, spectrum sale, Qualcomm partnership details.

Chloe Hall
ByChloe Hall- Senior Editor
|
0

Anterix Inc (ATEX) stock has achieved a 52-week high, reaching $59.44. This milestone reflects strong performance over the past year.

The stock has seen a 102.13% increase over 12 months and a 163% surge in the last six months. Currently trading at $58.42, the market cap stands at $1.07 billion.

This upward trend indicates robust investor confidence. According to Bond.az, the stock is trading near its 52-week high with strong returns across multiple timeframes.

In recent news, Anterix received FCC approval for an experimental license to test satellite direct-to-device communications in collaboration with Lynk Global, utilizing its 900 MHz spectrum.

Additionally, Anterix signed a 900 MHz spectrum sale agreement with Texas-New Mexico Power to enhance grid operations via a private wireless network for 2025-2027.

The company also expanded its partnership with Qualcomm Technologies to develop industrial-grade IoT chipsets, leveraging Snapdragon modems for 4G/5G connectivity on Anterix's platform.

These developments highlight Anterix's efforts to advance technology and strengthen partnerships in the utility and communications sectors.

More News
Today / 07:43
|
570

Ocado Admits 62,729 Shares to London Stock Exchange

Ocado Group plc admits 62,729 ordinary shares to trading on the London Stock Exchange under the Restricted Share Plan.

0
Today / 07:04
|
876

Avacta reports 2025 results, raises £32.5m for oncology trials

Avacta Group reports 2025 preliminary results, raises £32.5 million for oncology trials. Updates on AVA6103 and AVA6000 programs.

0
Today / 07:02
|
489

Greatland Issues Shares for Employee Incentive Plan

Greatland Resources issues 1.76 million shares for employee incentive plan at A$14.11 each. Shares to be admitted to AIM trading.

0
Today / 06:46
|
625

Kidney Transplant Rejection Test Study Published

Verici Dx's study on kidney transplant rejection test published in Kidney360. PTRA test predicts early acute rejection better than traditional tools.

0
Today / 06:45
|
716

Power Metallic forms Saudi joint venture with Amaar Mining

Power Metallic and Amaar Mining form 50/50 joint venture in Saudi Arabia. Initial funding of $10 million.

0
Today / 06:43
|
917

Bayer's asundexian gets FDA priority review

FDA grants Priority Review to Bayer's asundexian for secondary stroke prevention. Phase III trial results show promise.

0
Today / 06:33
|
784

Orosur Mining Issues 2.85M Shares After RSU Exercise

Orosur Mining issues 2.85M shares after directors and consultants exercise RSUs. Shares to trade on AIM from May 22, 2026.

0
Today / 06:31
|
965

Golden Prospect Moves Portfolio Management to Manulife

Golden Prospect Precious Metals delegates portfolio management to Manulife. New managers Diana Racanelli and Craig Bethune appointed.

0
Today / 06:22
|
948

SSP Group Appoints Candace McGraw to Board

SSP Group appoints Candace McGraw as independent non-executive director. Effective June 1, she brings aviation expertise.

0
Today / 06:01
|
902

CBL-514: New Obesity Data Revealed

Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.

0
Today / 05:21
|
881

Genentech to Present Breast Cancer Data at ASCO Meeting

Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.

0
Today / 03:43
|
453

Onto Innovation prices $1.3B convertible notes

Onto Innovation prices $1.3 billion convertible senior notes due 2031 at a 50% conversion premium. Interest-free notes with strong liquidity.

0
...